Simulations Plus Inc.
Chart
Good to know: Investing in stocks tends to provide long-term positive returns, but it also involves risks. You can lose some or all of your investment. Past performance of this stock is not a reliable indicator of future results. Data from external providers has not been altered by Saxo. See full data disclaimer
About Simulations Plus Inc.
Simulations Plus Inc is engaged in the software industry. It includes two segments. It develops and produces software for use in pharmaceutical research and education, and provides consulting and contract research services to the pharmaceutical industry. The company's operating segments include Software and services. The company offers software products for pharmaceutical research such as ADMET (Absorption, Distribution, Metabolism, Excretion, and Toxicity). It generates maximum revenue from the software segment. Maximum revenue is earned from USA following EMEA and Asia Pacific.
/ 
Frequently asked questions
To buy Simulations Plus Inc. stock, open a Saxo account and fund it. With SaxoInvestor or SaxoTrader, you can easily search for Simulations Plus Inc. by name or ticker, choose the number of shares, and place your order.
The ticker symbol for Simulations Plus Inc. is SLP:xnas. You can use this code to quickly find the stock in Saxo’s platforms and track its price and performance.
Simulations Plus Inc. has its primary listing on NASDAQ (Small cap). You can trade Simulations Plus Inc. with a Saxo account, alongside thousands of other stocks worldwide.
Yes, Simulations Plus Inc. is available to trade on SaxoInvestor and SaxoTraderGO. You can buy shares directly and include Simulations Plus Inc. as part of a broader investment portfolio. Explore our SaxoInvestor platform.
Learn more about investing and trading at Saxo’s educational content hub. Explore portfolio strategies, types of stocks, diversification, and valuation measures— so you can make more informed decisions when considering shares like Simulations Plus Inc..